Yesil, C. Et Al. 2015. Is BECLIN-1 Immunoreactivity More Effective than HBME-1 in Diagnosis of Papillary Thyroid Cancer ?. ACTA CHIRURGICA BELGICA , vol.115, no.4 , 299-305.

Yesil, C., Kandemir, O., Haksever, H., & Dabakoglu, T., (2015). Is BECLIN-1 Immunoreactivity More Effective than HBME-1 in Diagnosis of Papillary Thyroid Cancer ?. ACTA CHIRURGICA BELGICA , vol.115, no.4, 299-305.

Yesil, C. Et Al. "Is BECLIN-1 Immunoreactivity More Effective than HBME-1 in Diagnosis of Papillary Thyroid Cancer ?," ACTA CHIRURGICA BELGICA , vol.115, no.4, 299-305, 2015

Yesil, C. Et Al. "Is BECLIN-1 Immunoreactivity More Effective than HBME-1 in Diagnosis of Papillary Thyroid Cancer ?." ACTA CHIRURGICA BELGICA , vol.115, no.4, pp.299-305, 2015

Yesil, C. Et Al. (2015) . "Is BECLIN-1 Immunoreactivity More Effective than HBME-1 in Diagnosis of Papillary Thyroid Cancer ?." ACTA CHIRURGICA BELGICA , vol.115, no.4, pp.299-305.

@article{article, author={C. Yesil Et Al. }, title={Is BECLIN-1 Immunoreactivity More Effective than HBME-1 in Diagnosis of Papillary Thyroid Cancer ?}, journal={ACTA CHIRURGICA BELGICA}, year=2015, pages={299-305} }